by Dr. Joseph Mercola, Mercola:
STORY AT-A-GLANCE
- The 2023 omnibus appropriations bill includes 19 lines that could give the U.S. Food and Drug Administration the power to ban off-label use of approved medications
- If the little-noticed provision is passed, doctors’ ability to freely treat patients, and patients’ ability to use all available treatments after making an informed decision, will be lost
- The amendment puts the FDA, and by proxy Big Pharma, at the helm of powerful health care decisions that should be made on an individual, personalized level between a patient and their health care provider
